Gastric cancer is known as the second leading cause of cancer-related deaths worldwide. Despite a lot of advancements in the treatment of gastric cancer, the results of these treatments remain not so promising. The present article aims to highlight the pharmacotherapeutic aspect of gastric cancer with respect to disease remission, reducing morbidity rate and also preventing other complications of the disease. Gastric cancer is a malignant disease that generally has a poor long-term prognosis with the majority of patients being diagnosed in a much-advanced stage.
Despite various improvements in the treatment of gastric cancer, the prognosis remains poor. However, chemotherapy is the primary treatment for gastric cancer patients but targeted therapy can possibly improve the prognosis. Below is the list of medications that are indicated for patients with various stages of gastric cancer.…
